Self-healing microcapsules synergetically modulate immunization microenvironments for potent cancer vaccination.

Area of Science:

• Immunology
• Biomaterials Science
• Oncology

Background:

• Therapeutic cancer vaccines show promise but face challenges like unfavorable immune microenvironments and complex preparation.
• Existing methods often suffer from compromised vaccine performance due to these limitations.

Purpose of the Study:

• To develop a novel microcapsule-based formulation for high-performance cancer vaccinations.
• To create a favorable in situ immunization microenvironment for enhanced vaccine efficacy.
• To improve antigen utilization, presentation, and antigen-presenting cell activation.

Main Methods:

• Development of a self-healing microcapsule formulation for mild and efficient antigen microencapsulation.
• In situ creation of a favorable immunization microenvironment post-vaccination.
• Evaluation of antigen release kinetics, recruited cell behavior, and local acidity modulation.
• Encapsulation and assessment of various antigens, including neoantigens, in different tumor models.

Main Results:

• Achieved effective T cell response and potent tumor inhibition.
• Demonstrated significant antimetastatic effects and prevention of postsurgical recurrence.
• Validated the formulation's performance across diverse tumor models and antigen types.

Conclusions:

• The novel microcapsule formulation offers a promising strategy for advanced cancer vaccination.
• This approach effectively overcomes limitations of conventional cancer vaccines by optimizing the immunization microenvironment.
• The self-healing microcapsules provide a versatile platform for enhancing therapeutic cancer vaccine performance.